3016: How Creyon Bio is Using AI to Transform Drug Development
In this episode, I have an insightful conversation with Chris Hart, the CEO of Creyon Bio, to dive into how artificial intelligence is reshaping drug development. Creyon Bio is pioneering the use of AI to engineer Oligonucleotide-Based Medicines (OBMs), prioritizing safety in their approach to creating effective treatments. By applying cutting-edge technology, the company is able to streamline the identification of safe medicines, offering a more efficient path to drug discovery. One of the most compelling examples of their work is the recent treatment of a baby boy diagnosed with an ultra-rare disease caused by a mutation in the TNPO2 gene. In just 13 months, Creyon Bio developed a tailored treatment that marked a major milestone in the world of personalized medicine. Chris shares the story of this breakthrough, highlighting the role AI played in rapidly creating and testing a selective lock nucleic acid (LNA) antisense oligo, which led to significant improvements in the child's health. We also explore how Creyon Bio’s AI-driven platform addresses common challenges in drug development, from enhancing safety to optimizing delivery. Chris delves into how AI helps analyze complex data sets, enabling the rapid progression from identifying a target to developing a lead compound. This innovation is not only revolutionizing timelines but also increasing the probability of success in the often unpredictable world of biotech. Tune in to hear Chris’s valuable insights on the future of AI in medicine, the challenges the industry faces, and how Creyon Bio is pushing the boundaries of what’s possible in drug engineering. Could AI be the key to accelerating life-saving treatments for rare diseases?
Om Podcasten
If every company is now a tech company and digital transformation is a journey rather than a destination, how do you keep up with the relentless pace of technological change?
Every day, Tech Talks Daily brings you insights from the brightest minds in tech, business, and innovation, breaking down complex ideas into clear, actionable takeaways.
Hosted by Neil C. Hughes, Tech Talks Daily explores how emerging technologies such as AI, cybersecurity, cloud computing, fintech, quantum computing, Web3, and more are shaping industries and solving real-world challenges in modern businesses.
Through candid conversations with industry leaders, CEOs, Fortune 500 executives, startup founders, and even the occasional celebrity, Tech Talks Daily uncovers the trends driving digital transformation and the strategies behind successful tech adoption. But this isn't just about buzzwords.
We go beyond the hype to demystify the biggest tech trends and determine their real-world impact. From cybersecurity and blockchain to AI sovereignty, robotics, and post-quantum cryptography, we explore the measurable difference these innovations can make.
Whether improving security, enhancing customer experiences, or driving business growth, we also investigate the ROI of cutting-edge tech projects, asking the tough questions about what works, what doesn't, and how businesses can maximize their investments.
Whether you're a business leader, IT professional, or simply curious about technology's role in our lives, you'll find engaging discussions that challenge perspectives, share diverse viewpoints, and spark new ideas.
New episodes are released daily, 365 days a year, breaking down complex ideas into clear, actionable takeaways around technology and the future of business.